Order Article Reprints

Deng G, He J, Huang Q, Li T, Huang Z, Gao S, Xu J, Wang T, Di J. Ibrutinib Inhibits BTK Signaling in Tumor-Infiltrated B Cells and Amplifies Antitumor Immunity by PD-1 Checkpoint Blockade for Metastatic Prostate Cancer. Cancers. 2023; 15(8):2356. https://doi.org/10.3390/cancers15082356

Deng, Gengguo, Jiannan He, Qunxiong Huang, Tengcheng Li, Zhansen Huang, Shuntian Gao, Jinbin Xu, Tiantian Wang, and Jinming Di. 2023. "Ibrutinib Inhibits BTK Signaling in Tumor-Infiltrated B Cells and Amplifies Antitumor Immunity by PD-1 Checkpoint Blockade for Metastatic Prostate Cancer" Cancers 15, no. 8: 2356. https://doi.org/10.3390/cancers15082356

Deng, G., He, J., Huang, Q., Li, T., Huang, Z., Gao, S., Xu, J., Wang, T., & Di, J. (2023). Ibrutinib Inhibits BTK Signaling in Tumor-Infiltrated B Cells and Amplifies Antitumor Immunity by PD-1 Checkpoint Blockade for Metastatic Prostate Cancer. Cancers, 15(8), 2356. https://doi.org/10.3390/cancers15082356